TransCode Therapeutics, Inc. earnings per share and revenue

RNAZ earnings per share for the last quarter are -8.50 USD whereas the estimation was -105.93 USD which accounts for 91.98% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 300.00 k USD. Estimated earnings per share for the next quarter are -2.00 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of RNAZ earnings per share and revenue dynamics.